Zimbabwe Government Gazette dated 2012-12-14 number 69

ZIMBABWEAN

GOVERNMENT GAZETTE
Published by Authority

Vol. XC, No. 69 14th DECEMBER, 2012 Price US$2,00

General Notice 592 of 2012.
MEDICINES AND ALLIED SUBSTANCES CONTROL ACT [CHAPTER 15:03\

Approval of Registration of Human Medicines

IT is hereby notified, in terms of section 24( 1 )(b) of the Medicines and Allied Substances Control Act [Chapter 15:03], that the Medicines
Control Authority has approved the registration of the medicines specified in the Schedule.

G. N. MAHLANGU,
14-12-2012. Director-General.
Sc h e d u l e

F ile N o . A ppI N o . A p p ro v ed n a m e T V ad e S tre n g th F o rm . A p p lic a n t

4 2 2 5 0 0 F 6 8 2 H E P A T IT IS B S U R F A C E A N T IG E N S H A N V A C -B 2 0 M C O P E R M L U Q U ID S S H A N T H A B IO T E C H N IC S ( P V T ) L T D

4 2 2 6 0 0 0 G 4 1 A T E N O L O L N O V A T E N -5 0 5 0 M G T A B L E T S .C O A T E D A JA N T A P H A R M A L IM IT E D

4 2 2 7 0 0 G 1 2 J N E V IR A P IN E N E V IR A P IN E 2 0 0 M O T A B L E T S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D . H R E

4 2 3 0 0 0 F 9 3 7 T H IO P E N T O N E S O D IU M IN T R A M E D T H IO P E N T O N E S O D IU M 0 .5 G /2 0 M L P O W D E R S F O R IN J E C T IO N IN T R A M E D (P T Y ) L T D , K O R S T E N ,P E ,S A

4 2 3 3 0 0 0 G 8 8 S IB U T R A M IN E H C L M O N O H Y D R A T E S IB U T R IM -JO lO M G C A P S U L E S G L E N M A R K P H A R M A C E U T IC A L S L T D . IN D IA

4 2 3 4 O O G II8 E S O M E P R A Z O L E M A G N E S IU M T O IH Y D R A T E E S O Z -2 0 2 0 M G . T A B L E T S .C O A T E D G L E N M A R K P H A R M A C E U T IC A L S L T D , IN D IA

4 2 3 5 0 0 G II7 E S O M A P R A Z O L E M A G N E S IU M T R H Y D R A T E E S O Z -4 0 4 0 M G T A B L E T S . C O A T E D G l^ N M A R K P H A R M A C E U T IC A L S L T D . IN D IA

4 2 3 6 0 0 0 G 8 5 G L IM E P IR ID E G L IM U L IN -2 2 M G T A B L E T S G L E N M A R K P H A R M A C E U T IC A L S L T D , IN D IA

4 2 3 7 (K )0 G 7 8 A D A P A L E N E D E R IV A A Q U E O U S G E L 0 .1 % W W G E L S G L E N M A R K P H A R M A C E U T IC A L S L T D . IN D IA

4 2 3 9 0 0 G I2 2 N O R G E S T R E L & E T H IN Y L E S T R A D IO L L U S IA -F 0 .3 /0 .0 3 M G T A B L E F S . C O A T E D F A M Y C A R E L T D

4241 0 0 F 8 3 6 A L B E N D A Z O L E N E M O Z O L E 1 0 0 M O /5 M L S U S P E N S IO N S , O R A L IP C A L A B O R A T O R IE S L T D . IN D IA

4 2 4 2 Z 0 0 2 9 6 M A IN T E L Y T E M A IN T E L Y T E 2 .0 5 /I .8 6 /0 J I G , IN T R A V E N O U S S O L U T IO N S D A T L A B S P V T L T D . B U L A W A Y O .Z I M B A B W E

4 2 4 3 G 0 F 8 I9 C IP R O F L O X A C IN H Y D R O C H L O R ID E C lP R O X lN -5 0 0 5 0 0 M G T A B L E T S .C O A T E D U M E D iC A , M U M B A I, IN D IA

4 2 4 4 0 0 F 5 3 2 C E F T R IA X O N E C E F T R IA X O N E lO O M G /V lA L P O W D E R S F O R IN JE C H O N M IC R O L A B S L T D , B A N G A L O R E . IN D IA

4 2 4 5 0 0 F 3 7 I C IP R O F L O X A C IN H Y D R O C H L O R ID E M IC R O F L O X -5 0 0 5 0 0 M G /T A B L E T T A B L E T S M IC R O L A B S L T D . B A N G A L O R E , IN D IA

I 4 2 4 6

4 2 4 9
0 0 F 6 4 8

0 0 F 8 6 5
O M E P R A Z O L E

I R O N ( lll)H Y D R O X I D E

P O L Y M A L T O S E C O M P L E X
O M IC A P

O R O F E R
2 0 M G

5 0 M G
C A P S U L E S

S Y R U P S
M IC R O L A B S L T D , B A N G A L O R E , IN D IA

E M C U R E P H A R M A C E U T IC A L S L T D

4 2 5 0 0 0 F 6 2 4 C E T IR IZ IN E H Y D R O C H L O R ID E A L L E R C E T lO M G T A B L E T S , C O A T E D M IC R O L A B S L T D , B A N G A L O R E .I N D I A

4251 0 0 0 G 4 7 L A M IV U D IN E & S T A V U D IN E C O V IR O L S -3 0 1 5 0 /3 0 M G T A B L E T S R A N B A X V L A B S L T D , G U R G A O N , IN D IA

4 2 5 3 0 0 0 G 1 9 IB U P R O F E N IB U P R O F E N 2 0 0 M G T A B L E T S .C O A T E D F D C L I M I T E D . J O G E S H W A R I .IN D I A

4 2 5 4 0 0 0 G 2 0 IB U P R O F E N IB U P R O F E N 4 0 0 M G T A B L E T S .C O A T E D F D C L IM IT E D , JO G E S H W A R I. IN D IA

4 2 5 6 0 0 F 9 8 0 A T O R V A S T A T IN C A L C IU M L IP IT A S 2 0 2 0 M G T A B L E T S .C O A T E D IN T A S P H A R M A C E U T IC A L S L IM IT E D

4 2 5 7 O O F 769 L p S A R T A N P O T A S S IU M P R E S A R T A N -2 5 2 5 M G ' T A B L E T S IP C A L A B O R A T O R IE S L T D . IN D IA

4 2 5 8 0 0 F 77 O L O S A R T A N P O T A S S IU M P R E S A R T A N -5 0 5 0 M G T A B L E T S IP C A L A B O R A T O R IE S L T D , IN D IA

4 2 5 9 O O O O G 2 L A M IV U D IN E 3 T C 3 0 0 M C 3 0 0 M G T A B L E T S .C O A T E D G L A X O -W E L L C O M E Z IM B A B W E P V T

L T D . H A R A R E

4261 0 0 0 1 8 1 S T A V U D IN E S T A V U D IN E 3 0 M G 3 0 M G C A P S U L E S V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D . H R E

4 2 6 2 0 0 G 1 3 5 ro V ID O N E -IO D IN E P O V IC ID E 0 .1 G O IN T M E N T S P L U S F IV E P H A R M A C E U T IC A L S P V T

L T D , B U L A W A Y O

4 2 6 3 0 0 F 7 0 2 H Y O S C IN E C H L O R ID E , H Y O S C IN E C H L O R ID E lO M G T A B L E T S m o r n in o s id e ph a r m l t d .u k
4 2 6 5 0 0 G I4 8 G E L A T IN S U C C IN Y L G E L O F U S IN E 4 % 4 % IN F U S IO N S B . B R A U N M E L S U N G E N A G

(C O N C E N T R A T E D S O L U T IO N )

4 2 6 6 O O O G 58 A D R E N A L IN E A C ID T A R T R A T E A D R E N A U N E -F R E S E N iU S 1 .8 M G /1 0 0 0 M L S IN F U S IO N S INTRAMED (PTY) LTD, KORSTEN. PE,SA
4 2 6 8 0O F 887 C L O T R IM A Z O L E C A N D ID V -1 5 0 0 M G T A B L E T S GLENMARK PHARMACEUTICALS LTD. INDIA
4271 0 0 0 0 G 5 L IS IN O P R IL • ’
T O R R E N T -L IS IN O P R IL -5 5 M G T A B L E T S I . .TORRENT PHARMACEUTICALS INDIA
4 2 7 2 0O O O G 6 L IS IN O P R IL T O R R E N T -U S IN O P R IH O ]0 M G T A B L E T S TORRENT PHARMACEUTICALS INDIA
4 2 7 3 0 0 F 9 0 8 T R IF L U O P E R A Z IN E H Y D R O C H L O R ID E T R IF L U O P E R A Z IN E 5 T A B L E T S 5 M G T A B L E T S , C O A T E D REMEDICA LTD CYPRUS
4 2 7 4 O O G 107 P R E D N IS O N E P A N A F C O R T 5 M O T A B L E T S ADCOCK INGRAM LIMITED
4 2 7 7 0 0 0 0 8 0 N O R F L O X A C IN N O R F L O X A C IN 4 0 0 M G T A B L E T S .C O A T E D VARICHEM PHARMACEUTICALS (PVT) LTD, HRE
4 2 7 8 0 0 F 8 4 2 S A L B U T A M O L S A L B U T A M O L 4 M O T A B L E T S FLAMINGO PHARM CHEMBUR, MUMBAI. INDIA
4 2 7 9 O O O G 93 N A L ID IX IC A C ID N A L ID IX IC A Q D 5 0 0 M G T A B L E T S f ix : LIMITED, JOGESHWARI.INDIA
4 2 8 0 0 0 F 7 4 9 B E N Z Y L P E N IC IL L IN S O D IU M B E N Z Y L P E N IC IIU N S O D IU M 5 M U POWDERS FOR INJECTION UMEDICA. MUMBAI, INDIA
4281 0 0 G 2 0 1 K E T A M IN E H Y D R O C H L O R ID E K E T A M I N E - F R E S E N I U S 5 0 M O /M L 5 0 M G /M L IN JE C T IO N S IN T R A M E D (P T Y ) L T D . K O R S T E N , P E , S A

4 2 8 2 0 0 G 1 I4 A M O X Y C IL L IN T R IH Y D R A T E & P O T A S S IU M 8 7 5 /I2 5 M G T A B L E T S .C O A T E D R A N B A X Y L A B S L T D .
E N H A N C IN

C L A V U L A N A T E G U R G A O N . IN D IA

4 2 8 3 0 0 O G 2 6 A M O X Y C IL L IN T R IH Y D R A T E A M O X Y C IL L IN 1 2 5 M G /5 M L S U S P E N S IO N S , O R A L M IS S IO N P H A R M A A /S . D E N M A R K

4 2 8 4 . 0 0 0 1 9 2 IS O P H A N E IN S U L IN T O O IU /M L IN JE C T IO N S M ./ . B IO P H A R M A (P V T ) L T D
IN S U L ID D N

4 2 8 5 0 0 C 2 O 9 M E T H Y L D O P A 2 5 0 M G T A B L E T S .C O A T E D T A N T U R E IN V E S T M E N T S
D O P A T A B M 2 5 0 •

4 2 8 6 0 0 G I7 8 E R Y T H R O M Y C IN S T E A R A T E 2 5 0 M G T A B L E T S .C O A T E D IN D O C O R E M E D IE S L T D . , •
IN D O -2 5 0

4 2 8 9 O O G 146 P R O P O F O L lO M O /M L IN JE C T IO N S
P R O P O F O L * U P U R O I% B .B R A U N M E L S U N G E N A O

4 2 9 0 0 0 0 0 7 9 L A M IV U D IN E 150M O . '’ T A B L E T S .C O A T E D
L A M IV U D IN E V A R IC H E M P H A R M A C E U T IC A L S (P V T ) L T D , H R E